74 related articles for article (PubMed ID: 7650755)
21. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
22. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.
Widmer HR; Schaller B; Meyer M; Seiler RW
Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
Nagel F; Bähr M; Dietz GP
Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
[TBL] [Abstract][Full Text] [Related]
24. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
Michel PP; Agid Y
Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
[TBL] [Abstract][Full Text] [Related]
25. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K; Jones SA; Hyman C; Zimmer J
Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
[TBL] [Abstract][Full Text] [Related]
26. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
[TBL] [Abstract][Full Text] [Related]
27. Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro.
Kilic U; Kilic E; Lingor P; Yulug B; Bähr M
Acta Neuropathol; 2004 Jul; 108(1):65-8. PubMed ID: 15138778
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of proteoglycan synthesis affects neuronal outgrowth and astrocytic migration in organotypic cultures of fetal ventral mesencephalon.
Berglöf E; Plantman S; Johansson S; Strömberg I
J Neurosci Res; 2008 Jan; 86(1):84-92. PubMed ID: 17868150
[TBL] [Abstract][Full Text] [Related]
29. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
30. Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons.
Schaller B; Andres RH; Huber AW; Meyer M; Pérez-Bouza A; Ducray AD; Seiler RW; Widmer HR
Brain Res; 2005 Mar; 1036(1-2):163-72. PubMed ID: 15725414
[TBL] [Abstract][Full Text] [Related]
31. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation.
Li R; Peng N; Du F; Li XP; Le WD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):376-80. PubMed ID: 16624731
[TBL] [Abstract][Full Text] [Related]
33. Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.
Rojas P; Franco-Pérez JE; Rojas C; Rojas-Castañeda J; Ebadi M; Fernández-Valverde F; Serrano-García N
Neurotoxicology; 2005 Dec; 26(6):959-68. PubMed ID: 15950287
[TBL] [Abstract][Full Text] [Related]
34. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons.
Takeshima T; Shimoda K; Johnston JM; Commissiong JW
J Neurosci Methods; 1996 Jul; 67(1):27-41. PubMed ID: 8844522
[TBL] [Abstract][Full Text] [Related]
35. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
Koutsilieri E; Chen TS; Rausch WD; Riederer P
Eur J Pharmacol; 1996 Jun; 306(1-3):181-6. PubMed ID: 8813631
[TBL] [Abstract][Full Text] [Related]
36. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons.
Castilho RF; Hansson O; Brundin P
Exp Neurol; 2000 Jul; 164(1):94-101. PubMed ID: 10877919
[TBL] [Abstract][Full Text] [Related]
37. Elevated potassium enhances glutamate vulnerability of dopaminergic neurons developing in mesencephalic cell cultures.
Andreeva N; Ungethum U; Heldt J; Marschhausen G; Altmann T; Andersson K; Gross J
Exp Neurol; 1996 Feb; 137(2):255-62. PubMed ID: 8635540
[TBL] [Abstract][Full Text] [Related]
38. Asymmetrically lesioned mesencephalon in healthy rodents: call for caution.
Pioli EY; Dovero S; Bioulac BH; Gross CE; Bezard E
Brain Res; 2004 Oct; 1022(1-2):251-3. PubMed ID: 15353237
[TBL] [Abstract][Full Text] [Related]
39. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
Chan P; Di Monte DA; Langston JW; Janson AM
J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mesencephalic cultures after MPP+: the consequences of treatment with GM1 ganglioside.
Dalia A; Neff NH; Hadjiconstantinou M
Brain Res; 1996 Dec; 742(1-2):260-4. PubMed ID: 9117403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
